School of Medicine


Showing 31-40 of 130 Results

  • Sedona Ewbank

    Sedona Ewbank

    Postdoctoral Scholar, Psychiatry

    Current Research and Scholarly InterestsI am interested in using and developing systems neuroscience approaches to improve understanding and treatment of psychiatric illnesses. My current work is focused on developing translatable, noninvasive deep brain neuromodulation through targeted delivery of psychotropic drugs via ultrasound-sensitive nanoparticles.

  • Emily Ferguson, PhD

    Emily Ferguson, PhD

    Postdoctoral Scholar, Psychiatry

    BioEmily Ferguson, Ph.D., is a postdoctoral academic researcher and clinician within Stanford University’s Autism and Developmental Disorders Research Program (https://med.stanford.edu/autism.html) within the Department of Psychiatry and Behavioral Sciences. She earned her doctoral degree in Clinical Psychology from the University of California Santa Barbara and completed her clinical internship at the University of California Los Angeles. Dr. Ferguson's research focuses on advancing understanding of mechanisms of challenging behaviors in autistic youth and adults to inform treatment development. Her work takes a comprehensive perspective, integrating methods from implementation science to improve the accessibility and quality of clinical care for underserved autistic populations, especially those with higher support needs (or "profound autism"). She is also interested in developing methods to improve self-regulation in individuals with profound autism to effectively manage self-injurious behaviors and aggression. Dr. Ferguson is currently supporting research in the Preschool Autism Lab (https://med.stanford.edu/autismcenter/pre-school-autism-lab-program.html), and exploring profiles of challenging behaviors with the Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) in a diverse range of autistic and non-autistic youth to inform treatment approaches.

  • Yoshitaka Furuta

    Yoshitaka Furuta

    Postdoctoral Scholar, Psychiatry

    Current Research and Scholarly InterestsHuman brain organoids and neurodevelopmental disorders

  • Dina Ganji

    Dina Ganji

    Postdoctoral Scholar, Psychiatry

    BioDina Ganji, MD is a board-certified psychiatrist and Visiting Scholar at Stanford University, working at the intersection of clinical psychiatry, neuropsychiatry, and translational neuroscience. Her research focuses on integrating neuroimaging, neuromodulation techniques, and clinical phenotyping to advance precision psychiatry, with a particular emphasis on autism spectrum disorder, neurodevelopmental disorders, and cognitive neuroscience in children, as well as mood and substance use disorders.

    She has a strong and growing interest in autism, pediatric neurocognition, and broader neurodevelopmental conditions, with a particular focus on understanding cognitive and behavioral mechanisms in early development and translating these insights into more individualized and effective interventions.

    Dr. Ganji completed her Psychiatry Residency at Mashhad University of Medical Sciences, where she also gained extensive clinical experience in the diagnosis and treatment of a wide range of psychiatric disorders. She is a board-certified psychiatrist with clinical expertise in both inpatient and outpatient psychiatric care.

    At Stanford University, she has contributed to multiple interdisciplinary research programs. In Dr. Maldonado’s lab, she serves as a research coordinator for large-scale clinical and longitudinal studies, including delirium outcomes in patients (LUCIDIFY study), psychosocial assessment in transplant candidates (SIPAT project), and clinical cohorts involving CAR-T and hematopoietic stem cell therapy.

    Previously, in the Brain Stimulation Lab at Stanford, she gained hands-on experience in transcranial magnetic stimulation (TMS), including motor threshold assessment and clinical application of H-coil protocols in patients with OCD, depression and anxiety disorders. She also received training in functional MRI (fMRI) data acquisition and interpretation through advanced neuroscience courses.

    In Iran, she served as Research and Development Lead at Atrin Clinic, where she integrated repetitive TMS (rTMS), pharmacological treatment, and clinical assessment tools for patients with major depressive disorder, generalized anxiety disorder, and substance use disorders, while systematically monitoring treatment outcomes.

    Her research output includes multiple peer-reviewed publications in international journals, covering topics such as autism spectrum disorder, neuromodulation in bipolar disorder, congenital heart defects in vulnerable pediatric populations, neurocognitive effects of environmental exposure, and adjunctive treatments in psychiatric disorders.

    Beyond research, Dr. Ganji is actively involved in academic service, including conference organization, neuropsychiatry committee activities, and peer review for scientific journals. She has also completed professional training in mind-body medicine approaches.

    Dr. Ganji is deeply committed to patient-centered psychiatry and is particularly motivated by understanding autism, neurodevelopmental disorders, and pediatric cognitive neuroscience. She aims to bridge neuroscience and clinical psychiatry to develop more precise, individualized interventions that improve outcomes in children and patients with complex psychiatric and neurodevelopmental conditions.

  • Juan Sebastián Gómez-Cañón

    Juan Sebastián Gómez-Cañón

    Postdoctoral Scholar, Psychiatry

    BioJuan S. Gómez-Cañón is a researcher, engineer and musician from Colombia. He holds a Ph.D. in Information and Communication Technologies from the Universitat Pompeu Fabra (Barcelona, Spain). During his Ph.D., Juan researched human-centered and trustworthy machine learning methods to predict the emotions in music. His research focuses on deep learning, human-centered ML, personalization, dataset curation, and digital signal processing. Juan also holds a M.Sc. in Media Technology (Technische Universität Ilmenau, Germany), a B.Sc. in Electronics Engineering and a B.A. in Music (Universidad de los Andes, Colombia).

  • John Lyon Havlik

    John Lyon Havlik

    Postdoctoral Medical Fellow, Psychiatry
    Resident in Psychiatry and Behavioral Sciences

    BioHello! I'm the inaugural Humanities and Social Medicine research track resident at Stanford University.

    Psychiatric and substance use disorders are usually caught only after substantial and sometimes irreparable harm has already occurred. My research program is focused on changing this in two ways. Number one, I build artificial intelligence models that identify people with psychiatric and substance use disorders earlier. I believe this kind of early intervention will one day be commonplace and prevent a great deal of human suffering. Number two, I evaluate whether the systems that receive them, like health plans, treatment facilities, and now generative AI chatbots, are equipped to respond appropriately. There is much work to do here.

    On the building side, I have developed a machine learning model that detects untreated substance use disorders from EHR-like data, published in Nature Mental Health; related work uses multimodal data to flag who will go on to develop substance use disorders and to predict imminent psychiatric emergency-department visits. I work across a wide range of deterministic and probabilistic methods, including the transformer architectures behind modern "chatbots." My work has been featured in 40+ peer-reviewed publications in venues such as Nature Medicine, NeurIPS, Science Advances, Nature Mental Health, JAMA Health Forum, and featured in national news outlets. But publications matter little to the lives of my patients. My aim is to develop models that are clinically useful. This aim has been met with some degree of success as spinout AI-enabled clinical workflow automation software I developed is in use at the U.S. Department of Veterans Affairs and here at Stanford.

    On the evaluating side, I serve as an expert reviewer of AI-in-medicine trials for the State of Utah's Office of Artificial Intelligence Policy, and I am a sought-after health-tech advisor for Silicon Valley's leading venture capital firms and companies. I write on psychiatric services and health policy, recently in JAMA Health Forum on private-equity residential treatment and JAMA Network Open on the economics of telemedicine "house calls". I also recently co-authored a Nature Medicine paper on how to rigorously test the true capabilities of medical AI and lead ongoing research in this area.

    Alongside my research, I have an enduring interest in medical education and founded and lead Research Roundtable, a psychiatric services research group whose undergraduates have published 10+ first-author papers. Before medicine, with Peggy Mason at UChicago, I found the human bystander effect in rats (Science Advances).